Core Laboratories N.V. (CLB) Tops Q2 EPS by 1c, Offers Guidance
Get Alerts CLB Hot Sheet
EPS Growth %: -63.2%
Financial Fact:
Net Income (Loss) Attributable to Non-controlling Interest: 108K
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Core Laboratories N.V. (NYSE: CLB) reported Q2 EPS of $1.35, $0.01 better than the analyst estimate of $1.34. Revenue for the quarter came in at $267.6 million versus the consensus estimate of $269.7 million.
Core Laboratories N.V. sees Q3 2014 EPS of $1.49-$1.52, versus the consensus of $1.52. Core Laboratories N.V. sees Q3 2014 revenue of $280-290 million, versus the consensus of $284.6 million.
Core Laboratories N.V. sees Q4 2014 EPS of $1.56-$1.61. Core Laboratories N.V. sees Q4 2014 revenue of $285-295 million.
For earnings history and earnings-related data on Core Laboratories N.V. (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Chevron (CVX) Misses Q1 EPS by 3c
- Centene (CNC) Tops Q1 EPS by 18c; Raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!